Mauguen, A. Et Al. 2013. Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. LANCET ONCOLOGY , vol.14 , 619-626.

Mauguen, A., Pignon, J., Burdett, S., Domerg, C., Fisher, D., Paulus, R., ... Mandrekar, S.(2013). Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. LANCET ONCOLOGY , vol.14, 619-626.

Mauguen, Aa Et Al. "Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data," LANCET ONCOLOGY , vol.14, 619-626, 2013

Mauguen, Aa Et Al. "Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data." LANCET ONCOLOGY , vol.14, pp.619-626, 2013

Mauguen, A. Et Al. (2013) . "Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data." LANCET ONCOLOGY , vol.14, pp.619-626.

@article{article, author={Aa Mauguen Et Al. }, title={Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data}, journal={LANCET ONCOLOGY}, year=2013, pages={619-626} }